Scarica l'app Stockscreener
1.22
1.61%
-0.02
Dopo l'orario di chiusura:
1.22
Precedente Chiudi:
$1.24
Aprire:
$1.225
Volume 24 ore:
178.28K
Relative Volume:
0.29
Capitalizzazione di mercato:
$30.93M
Reddito:
-
Utile/perdita netta:
$-10.21M
Rapporto P/E:
-2.0883
EPS:
-0.5842
Flusso di cassa netto:
-
1 W Prestazione:
-2.40%
1M Prestazione:
+4.27%
6M Prestazione:
+18.33%
1 anno Prestazione:
+24.55%
Intervallo 1D:
$1.19
$1.27
Intervallo di 1 settimana:
$1.17
$1.27
Portata 52W:
$0.80
$2.60
Neurosense Therapeutics Ltd Stock (NRSN) Company Profile
Nome
Neurosense Therapeutics Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta NRSN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NRSN
Neurosense Therapeutics Ltd
|
1.22 | 30.93M | 0 | -10.21M | 0 | -0.5842 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Neurosense Therapeutics Ltd Borsa (NRSN) Ultime notizie
How to build a custom watchlist for NeuroSense Therapeutics Ltd.Market Trend Review & Reliable Entry Point Alerts - newser.com
What institutional flow reveals about NeuroSense Therapeutics Ltd.Portfolio Growth Summary & Long-Term Investment Growth Plans - newser.com
NeuroSense Therapeutics (NASDAQ:NRSN) Raised to Strong-Buy at Noble Financial - Defense World
Is NeuroSense Therapeutics Ltd. stock poised for growthWeekly Profit Report & Detailed Earnings Play Strategies - newser.com
Is NeuroSense Therapeutics Ltd. stock a safe haven assetExit Point & AI Driven Price Predictions - newser.com
How moving averages guide NeuroSense Therapeutics Ltd. Equity Warrant tradingChart Signals & Proven Capital Preservation Tips - newser.com
Historical volatility pattern of NeuroSense Therapeutics Ltd. Equity Warrant visualizedAnalyst Downgrade & Stepwise Entry and Exit Trade Signals - newser.com
Technical signs of recovery in NeuroSense Therapeutics Ltd. Equity WarrantEarnings Summary Report & Verified High Yield Trade Plans - newser.com
How NeuroSense Therapeutics Ltd. Equity Warrant stock performs in stagflationTrade Analysis Summary & Safe Entry Trade Reports - newser.com
What momentum indicators show for NeuroSense Therapeutics Ltd. stockPortfolio Value Summary & AI Forecasted Stock Moves - newser.com
Is NeuroSense Therapeutics Ltd. (H1Z) stock undervalued after correctionIndex Update & Fast Entry High Yield Stock Tips - newser.com
Visualizing NeuroSense Therapeutics Ltd. Equity Warrant stock with heatmapsEarnings Growth Report & Free Expert Verified Stock Movement Alerts - newser.com
Will NeuroSense Therapeutics Ltd. stock continue dividend increases2025 Trading Recap & Daily Stock Trend Reports - newser.com
Will NeuroSense Therapeutics Ltd. Equity Warrant stock maintain dividend yield2025 Major Catalysts & Weekly High Return Opportunities - newser.com
Will NeuroSense Therapeutics Ltd. (H1Z) stock draw ESG focused fundsWeekly Stock Analysis & Capital Efficiency Focused Ideas - newser.com
Can a trend reversal in NeuroSense Therapeutics Ltd. lead to recoveryEarnings Recap Report & Fast Gaining Stock Reports - newser.com
Is it too late to sell NeuroSense Therapeutics Ltd.July 2025 Levels & Stepwise Entry and Exit Trade Signals - newser.com
Evaluating NeuroSense Therapeutics Ltd. with trendline analysis2025 Analyst Calls & Safe Entry Point Identification - newser.com
Smart tools for monitoring NeuroSense Therapeutics Ltd.’s price actionJuly 2025 Patterns & Daily Profit Maximizing Tips - newser.com
Volume spikes in NeuroSense Therapeutics Ltd. stock – what they meanJuly 2025 Update & Short-Term Swing Trade Alerts - newser.com
Using R and stats models for NeuroSense Therapeutics Ltd. Equity Warrant forecasting2025 Top Gainers & Community Verified Swing Trade Signals - newser.com
How sentiment analysis helps forecast NeuroSense Therapeutics Ltd. Equity WarrantSwing Trade & Reliable Intraday Trade Plans - newser.com
Will NeuroSense Therapeutics Ltd. stock return to pre crisis levelsJuly 2025 Volume & Daily Stock Trend Watchlist - newser.com
Using economic indicators to assess NeuroSense Therapeutics Ltd. Equity Warrant potentialWeekly Trade Review & Daily Chart Pattern Signal Reports - newser.com
Using data filters to optimize entry into NeuroSense Therapeutics Ltd.Weekly Stock Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
Can NeuroSense Therapeutics Ltd. Equity Warrant rally from current levelsTrade Analysis Summary & Safe Entry Point Identification - newser.com
Real time scanner hits for NeuroSense Therapeutics Ltd. explained2025 Risk Factors & Long-Term Safe Investment Plans - newser.com
Backtesting results for NeuroSense Therapeutics Ltd. trading strategiesTrade Signal Summary & AI Forecasted Entry/Exit Points - newser.com
NeuroSense Therapeutics Ltd. stock momentum explainedInsider Selling & Stock Portfolio Risk Management - newser.com
NeuroSense Therapeutics (NASDAQ:NRSN) Shares Down 1.7% – Time to Sell? - Defense World
NeuroSense: PrimeC Produces Statistically Significant Reductions in Alzheimer's Disease Biomarkers - Sahm
Why NeuroSense Therapeutics Ltd. (H1Z) stock attracts wealthy investorsJuly 2025 Volume & Consistent Growth Equity Picks - newser.com
NeuroSense Announces Promising Alzheimer’s Biomarker Reductions with PrimeC - TipRanks
Neurosense Therapeutics Ltd Azioni (NRSN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):